Predicting allostery and microbial drug resistance with molecular simulations
نویسندگان
چکیده
منابع مشابه
microbial colonization and drug resistance in patients with cystic fibrosis
background cystic fibrosis (cf) is a genetic disease with an autosomal recessive pattern of inheritance. cf caused by a mutation in the cystic fibrosis transmembrane conductance regulator (cftr) gene and characterized by impaired transport of chloride ions across the cell membrane. staphylococcus aureus, pseudomonas aeruginosa, and burkholderia cepacia have been identified in the cultures of re...
متن کاملPredicting HIV drug resistance with neural networks
MOTIVATION Drug resistance is a very important factor influencing the failure of current HIV therapies. The ability to predict the drug resistance of HIV protease mutants may be useful in developing more effective and longer lasting treatment regimens. METHODS The HIV resistance is predicted to two current protease inhibitors, Indinavir and Saquinavir. The problem was approached from two pers...
متن کاملRevealing Atomic-Level Mechanisms of Protein Allostery with Molecular Dynamics Simulations
Molecular dynamics (MD) simulations have become a powerful and popular method for the study of protein allostery, the widespread phenomenon in which a stimulus at one site on a protein influences the properties of another site on the protein. By capturing the motions of a protein's constituent atoms, simulations can enable the discovery of allosteric binding sites and the determination of the m...
متن کاملChronic arsenic exposure and microbial drug resistance.
Resistance to antimicrobial drugs represents one of the greatest threats to the control of infectious diseases and is a particular problem in treating diseases caused by parasitic protists. These pathogens are of enormous medical importance, causing diseases such as malaria, toxoplasmosis, trypanosomiasis, and leishmaniasis. In the absence of effective vaccines, the control of these diseases is...
متن کاملPredicting outcomes and drug resistance with new standardised treatment.
In their hypothetical cohorts OXLADE et al. [1] predicted significant public-health benefits by changing from the 8-month to the 6-month (2HRZE/6HE to 2HRZE/4HR; where H5isoniazid, R5rifampicin, Z5pyrazinamide and E5ethambutol) regimen. Data from 2008 on drug-resistance surveillance from five World Health Organization (WHO) regions, i.e. Africa (Botswana), Western Pacific (China), Africa (Mozam...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Current Opinion in Structural Biology
سال: 2018
ISSN: 0959-440X
DOI: 10.1016/j.sbi.2018.09.001